• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】17929

【品名】ethyl 3-ethoxy-3-iminopropanoate

【CA登记号】2318-25-4

【 分 子 式 】C7H13NO3

【 分 子 量 】159.18516

【元素组成】C 52.82% H 8.23% N 8.8% O 30.15%

与该中间体有关的原料药合成路线共 4 条

合成路线1

该中间体在本合成路线中的序号:(VI)

Conjugated addition of 2-nitroaniline (I) to acrylonitrile (II) in the presence of Triton B in dioxane yielded propionitrile (III), which was hydrogenated to the phenylenediamine (IV). Treatment of ethyl cyanoacetate (V) with a cold saturated solution of HCl in absolute ethanol gave ethyl ethoxycarbonylacetimidate hydrochloride (VI). Reaction of this acetimidate (VI) with phenylenediamine (IV) in refluxing ethanol afforded the benzimidazole (VII), which was converted to the diester (VIII) on treatment with ethanolic HCl. Dieckmann condensation of diester (VIII) in the presence of sodium ethoxide furnished the tricyclic ketoester (IX), which was finally condensed with 2,6-difluoroaniline (X) in refluxing xilene to afford the target carboxamide.

1 Maryanoff, B.E.; et al.; Potential anxiolytic agents. Pyrido[1, 2-a]benzimidazoles: A new structural class of ligands for the benzodiazepine binding site on GABA-A receptors. J Med Chem 1995, 38, 1, 16.
2 Maryanoff, B.E.; McComsey, D.F.; Winston, H. (Ortho-McNeil Pharmaceutical, Inc.); 3-Oxo-pyrido(1,2-a)benzimidazole-4-carboxyl and 4-oxo-azepino(1,2-a)benzimidazole-5-carboxyl derivs. useful in treating central nervous system disorders. EP 0656002; WO 9404532 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 11608 o-Nitroaniline; 2-Nitroaniline; 2-Nitrophenylamine 88-74-4 C6H6N2O2 详情 详情
(II) 10847 Acrylonitrile 107-13-1 C3H3N 详情 详情
(III) 17926 3-(2-nitroanilino)propanenitrile C9H9N3O2 详情 详情
(IV) 17927 3-(2-aminoanilino)propanenitrile C9H11N3 详情 详情
(V) 11877 Cyanoacetic acid ethyl ester; Ethyl 2-cyanoacetate; Ethyl cyanoacetate; Ethyl isocyanacetate 105-56-6 C5H7NO2 详情 详情
(VI) 17929 ethyl 3-ethoxy-3-iminopropanoate 2318-25-4 C7H13NO3 详情 详情
(VII) 17930 ethyl 2-[1-(2-cyanoethyl)-1H-benzimidazol-2-yl]acetate C14H15N3O2 详情 详情
(VIII) 17931 ethyl 3-[2-(2-ethoxy-2-oxoethyl)-1H-benzimidazol-1-yl]propanoate C16H20N2O4 详情 详情
(IX) 17932 ethyl 3-oxo-1,2,3,5-tetrahydropyrido[1,2-a]benzimidazole-4-carboxylate C14H14N2O3 详情 详情
(X) 17933 2,6-Difluorophenylamine; 2,6-Difluoroaniline 5509-65-9 C6H5F2N 详情 详情

合成路线2

该中间体在本合成路线中的序号:(V)

Addition of acrylonitrile (II) to 3,4-difluoro-2-nitroaniline (I) gave the anilinopropionitrile (III). Subsequent hydrogenation of the nitro group of (III) over Pd/C led to the phenylenediamine (IV), which was condensed with carbethoxyacetimidate-HCl (V) to produce the benzimidazole (VI). After conversion of the nitrile group of (VI) to ester (VII) with ethanolic HCl, Dieckmann condensation using NaOEt furnished the cyclic ketoester (VIII). Finally, reaction of (VIII) with 2,6-difluoroaniline (IX) in xylene yielded the target carboxamide.

1 Maryanoff, B.E.; et al.; Potential anxiolytic agents. Pyrido[1, 2-a]benzimidazoles: A new structural class of ligands for the benzodiazepine binding site on GABA-A receptors. J Med Chem 1995, 38, 1, 16.
2 Nortey, S.O.; Sanfilippo, P.J.; Dubinsky, B.; Maryanoff, B.E.; McComsey, D.F.; Reitz, A.B.; Shank, R.P.; McNally, J.J.; Potential anxiolytic agents. 3. Novel A-ring modified pyrido[1,2-a]benzimidazoles. Bioorg Med Chem Lett 1999, 9, 11, 1547.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 31347 3,4-difluoro-2-nitrophenylamine; 3,4-difluoro-2-nitroaniline C6H4F2N2O2 详情 详情
(II) 10847 Acrylonitrile 107-13-1 C3H3N 详情 详情
(III) 31348 3-(3,4-difluoro-2-nitroanilino)propanenitrile C9H7F2N3O2 详情 详情
(IV) 31349 3-(2-amino-3,4-difluoroanilino)propanenitrile C9H9F2N3 详情 详情
(V) 17929 ethyl 3-ethoxy-3-iminopropanoate 2318-25-4 C7H13NO3 详情 详情
(VI) 31350 ethyl 2-[1-(2-cyanoethyl)-4,5-difluoro-1H-benzimidazol-2-yl]acetate C14H13F2N3O2 详情 详情
(VII) 31351 ethyl 3-[2-(2-ethoxy-2-oxoethyl)-4,5-difluoro-1H-benzimidazol-1-yl]propanoate C16H18F2N2O4 详情 详情
(VIII) 31352 ethyl 6,7-difluoro-3-oxo-1,2,3,5-tetrahydropyrido[1,2-a]benzimidazole-4-carboxylate C14H12F2N2O3 详情 详情
(IX) 17933 2,6-Difluorophenylamine; 2,6-Difluoroaniline 5509-65-9 C6H5F2N 详情 详情

合成路线3

该中间体在本合成路线中的序号:(IV)

The reduction of 3,4-dinitrobenzoic acid amide (I) with H2 over Pd/C in methanol gives 3,4-diaminobenzoic acid (II), which is cyclized with 3-ethoxy-3-iminopropionic acid ethyl ester (IV) (obtained by reaction of cyanacetic acid ethyl ester (III) with ethanolic HCl) in hot acetic acid to yield 2-(5-carbamoyl-1H-benzimidazol-2-yl)acetic acid ethyl ester (V). The reaction of 3-methoxy-4-nitrobenzoic acid (VII) with aqueous methylamine in a sealed tube at 100 C gives 3-(methylamino)-4-nitrobenzoic acid (VIII), which is reduced with H2 over Pd/C in methanol/THF to yield 4-amino-3-(methylamino)benzoic acid (VI). The cyclization of (VI) with (V) by means of 1,3-dimethylperhydropyrimidin-2-one (DMPU) at 190 C affords the substituted bis-benzimidazolylmethyl (IX). The reaction of (IX) with 2-amino-3-phosponopropionic acid tris-trimethylsilyl ester (X) (prepared by esterification of 2-amino-3-phosphonopropionic acid (XI) with N-methyl-N-(trimethylsilyl)trifluoroacetamide (XII)) by means of (PyBroP) in DMF provides the carboxamide (XIII). Finally, the cleavage of the trimethylsilyl ester groups by means of TFA furnishes the target phosphonic acid.

1 Rice, K.; Wang, V.R.; Hataye, J.M.; Shelton, E.J.; Spender, J.R. (Celera Genomics); Novel cpds. and compsns. for treating hepatitis C infections. WO 0020400 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 55559 3,4-dinitrobenzamide C7H5N3O5 详情 详情
(II) 55560 3,4-diaminobenzamide C7H9N3O 详情 详情
(III) 11877 Cyanoacetic acid ethyl ester; Ethyl 2-cyanoacetate; Ethyl cyanoacetate; Ethyl isocyanacetate 105-56-6 C5H7NO2 详情 详情
(IV) 17929 ethyl 3-ethoxy-3-iminopropanoate 2318-25-4 C7H13NO3 详情 详情
(V) 55561 ethyl 2-[5-(aminocarbonyl)-1H-benzimidazol-2-yl]acetate C12H13N3O3 详情 详情
(VI) 14729 4-amino-3-(methylamino)benzoic acid C8H10N2O2 详情 详情
(VII) 21085 3-methoxy-4-nitrobenzoic acid;4-Nitro-3-methoxybenzoic acid 5081-36-7 C8H7NO5 详情 详情
(VIII) 14728 3-(methylamino)-4-nitrobenzoic acid C8H8N2O4 详情 详情
(IX) 55562 2-{[5-(aminocarbonyl)-1H-benzimidazol-2-yl]methyl}-1-methyl-1H-benzimidazole-6-carboxylic acid C18H15N5O3 详情 详情
(X) 55563 3-{bis[(trimethylsilyl)oxy]phosphoryl}alanine C9H24NO5PSi2 详情 详情
(XI) 55565 DL-2-Amino-3-phosphonopropionic acid; 2-Amino-3-phosphonopropionic acid 20263-06-3 C3H8NO5P 详情 详情
(XII) 21859 2,2,2-trifluoro-N-methyl-N-(trimethylsilyl)acetamide C6H12F3NOSi 详情 详情
(XIII) 55564 N-[(2-{[5-(aminocarbonyl)-1H-benzimidazol-2-yl]methyl}-1-methyl-1H-benzimidazol-6-yl)carbonyl]-3-{bis[(trimethylsilyl)oxy]phosphoryl}alanine C27H37N6O7PSi2 详情 详情

合成路线4

该中间体在本合成路线中的序号:(II)

The cyclization of the phenylenediamine (I) with 3-ethoxy-3-iminopropionic acid ethyl ester (II) in refluxing ethanol gives the 2-(benzimidazol-2-yl)acetate (III), which is submitted to a new cyclization with 2-aminobenzonitrile (IV) by means of LiHMDS in THF to afford the target quinolinone.

1 Harris, A.; Renhowe, P.; Machajewski, T.; Shafer, C.; Wernette-Hammond, M.-E.; Pecchi, S.; Taylor, C.; McCrea, B.; McBride, C.; Jazan, E. (Chiron Corp.); Quinolinone derivs.. WO 0222598 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 53573 2-amino-4-[(3S)-3-(dimethylamino)pyrrolidinyl]phenylamine; 4-[(3S)-3-(dimethylamino)pyrrolidinyl]-1,2-benzenediamine n/a C12H20N4 详情 详情
(II) 17929 ethyl 3-ethoxy-3-iminopropanoate 2318-25-4 C7H13NO3 详情 详情
(III) 53574 ethyl 2-{5-[(3S)-3-(dimethylamino)pyrrolidinyl]-1H-benzimidazol-2-yl}acetate n/a C17H24N4O2 详情 详情
(IV) 19493 2-aminobenzonitrile 1885-29-6 C7H6N2 详情 详情
Extended Information